About: Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 1994

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 1994 (uk) article scientifique publié en 1994 (fr) im Oktober 1994 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 1994 (ast) scientific article published on 01 October 1994 (en)
publication date	wds:Q72559006-A99FF9AF-5D2C-4377-8E21-6409F54E4A46
publication date	1994-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72559006-522695C6-196C-49AC-9D1A-C4695D3DBCE4
language of work or name	English
exact match	wds:Q72559006-4F4B5D49-E9B2-4266-AA31-DCADE200E85E
exact match	https://scigraph.springernature.com/pub.10.1038/ki.1994.380
cites work	wds:Q72559006-0AD6F11E-3A86-470B-9FDC-19B5532BD932 wds:Q72559006-0E18F505-A191-4D10-8F75-BCCE78A05B58 wds:Q72559006-0F83618F-80C4-49C1-8FAC-B688E206AA8E wds:Q72559006-252B44A8-98F3-4110-8F23-6CDCAD5017FE wds:Q72559006-2959D013-EBD1-4B07-AE13-7441E7C2E267 wds:Q72559006-2C05ECD9-795D-4323-BA78-68DC0C79D77C wds:Q72559006-3240571E-8F29-45C1-B780-0FAAEDF748C6 wds:Q72559006-34DD0195-86C0-4E85-A42E-1F99931E890C wds:Q72559006-480E13EF-1AFF-4EAE-B5FA-0ACA0395545C wds:Q72559006-4F911314-4BDE-423E-8081-7087DBCC9505 wds:Q72559006-5E3030AF-C9F9-417C-916E-40596A618039 wds:Q72559006-5F3DEE84-E8CD-4995-BA75-E4E0492E21EA wds:Q72559006-8FD62090-F309-456D-834C-2E6187148D9F wds:Q72559006-9BEB43BA-7507-4BBB-B97F-E9F8668810CA wds:Q72559006-9F9C83F2-FB20-4AD6-B8E4-D9CA45EFD54E wds:Q72559006-B41CC0A8-60B8-4C26-8581-38D681DDC9DE wds:Q72559006-C36EB6BD-99B5-4C41-B22E-7F8265151000 wds:Q72559006-C6D80993-961E-4494-AB13-A7FC0E18192D wds:Q72559006-C71BB4DB-6DE9-4DBD-A802-95CB297A0045 wds:Q72559006-F50698F6-7834-4EB1-9DFA-2EE4B4957CB7 wds:Q72559006-FFAFB6D3-679C-4E3B-9277-E1238AB608FB
cites work	A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee Nutritional status of children undergoing continuous ambulatory peritoneal dialysis Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD The spectrum of bone disease in end-stage renal failure--an evolving disorder Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure 1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium Effect of hormones and growth factors on alkaline phosphatase activity and collagen synthesis in cultured rat calvariae Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function Pharmacokinetics of calcitriol in continuous ambulatory and cycling peritoneal dialysis patients The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients Evolution of secondary hyperparathyroidism during oral calcitriol therapy in pediatric renal osteodystrophy Hormonal control of bone collagen synthesis in vitro: inhibitory effect of 1-hydroxylated vitamin D metabolites Effects of parathyroidectomy on bone formation and mineralization in hemodialyzed patients Oral and parenteral calcitriol for the management of end-stage renal disease 1,25-Dihydroxyvitamin D3 and the skin: a unique application for the treatment of psoriasis.
author name string	wds:Q72559006-302331DC-FD00-4B0E-AD99-2DEF23DD8C0F wds:Q72559006-30B56B42-C33F-42B1-BCB8-A2E6C7C618B9 wds:Q72559006-3AA9C8A7-9FC9-4ACC-991C-837D94AF3CCB wds:Q72559006-5708C1AE-891B-48F2-83C0-0F3F1E77E53F wds:Q72559006-706FCDAF-EED6-4E3D-A2A0-01B59EA59B78 wds:Q72559006-77400BCD-E20C-438F-97AC-DB6A3ED206A8 wds:Q72559006-B4E8A5EC-4593-49FA-A830-04FF06F12D05
author name string	W G Goodman J A Ramirez T R Belin I B Salusky G V Segre B Gales Y Chon
rdfs:label	Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy (en) Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy (nl)
skos:prefLabel	Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy (en) Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy (nl)
name	Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy (en) Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy (nl)
title	wds:Q72559006-407CE362-9D0F-4690-9500-078DE3E9EEED
title	Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy (en)
page(s)	wds:Q72559006-092B91B4-ED03-4C3D-B30F-1C81E18C8DAD
page(s)	1160-1166
instance of	wds:Q72559006-9BEEA152-87C0-4A0C-A64C-3198EB65A268
instance of	scholarly article
main subject	wds:Q72559006-97DB1EB9-5562-4CC8-B9B7-93E80657E67C
main subject	secondary hyperparathyroidism
PubMed ID	wds:Q72559006-08EA9A98-0533-4C1E-A7D1-FEBA58475820
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7861712
PubMed ID	7861712
published in	wds:Q72559006-39E1D012-7A07-494A-A7B9-DA246941C047
published in	Kidney International
issue	wds:Q72559006-DCE2CF39-696A-4CAE-A6B7-2D865D7CFC19
volume	wds:Q72559006-362020D6-A282-4717-A26A-AD51C75C8BF2
issue	4
volume	46
DOI	wds:Q72559006-ABB469FA-A83C-4F92-A5BF-B45B699F8630
DOI	http://dx.doi.org/10.1038/KI.1994.380
DOI	10.1038/KI.1994.380
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72559006
is cites work of	Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation Calcium regulation and bone mineral metabolism in elderly patients with chronic kidney disease 1,25(OH)2D3 alters growth plate maturation and bone architecture in young rats with normal renal function Chronic kidney disease mineral and bone disorder in children

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software